Medikamentöse therapie der rheumatoiden arthritis

Translated title of the contribution: Current drug therapy in rheumatoid arthritis

T. A. Bongartz, O. Distler, U. Müller-Ladner

Research output: Contribution to journalReview articlepeer-review

Abstract

The introduction of novel, very effective drugs in the therapeutic armamentarium for the treatment of rheumatoid arthritis has not completely altered the general strategy but has led to a substantially improved situation for the affected patients. The current state-of-the-art includes non-steroidal antirheumatic drugs and low-dose steroids in combination with conventional disease-modifying drugs and biologics. However, owing to the complex character of the disease, a tight collaboration between the rheumatologist and the general practitioner is mandatory for the overall success of the long-term therapeutic regimen of the individual patient.

Translated title of the contributionCurrent drug therapy in rheumatoid arthritis
Original languageGerman
Pages (from-to)141-151
Number of pages11
JournalInternistische Praxis
Volume46
Issue number1
StatePublished - Mar 1 2006

Keywords

  • Biologics
  • Coxibs
  • NSAID
  • Rheumatoid arthritis
  • Steroids

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Current drug therapy in rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this